H1B Report
H-1B sponsorNCFEIN 80-0058312Updated Sep 2026

KBI Biopharma, Inc.

US H-1B Labor Condition Application activity for KBI Biopharma, Inc.. Filed 114 disclosures between FY2010 and FY2026 from worksites with a NC headquarters indicator.

Total filings
10
Outside top-N · FY2026
Certified
90.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
10.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of KBI Biopharma, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 90.3%, Cert-withdrawn 4.4%, Withdrawn 1.8%, Denied 3.5%
Outcome breakdown
OutcomeShare
Certified90.3%
Cert-withdrawn4.4%
Withdrawn1.8%
Denied3.5%
Certified90.3%
Cert-withdrawn4.4%
Withdrawn1.8%
Denied3.5%

Top occupations sponsored

SOC codes filed most by KBI Biopharma, Inc. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY20102
FY20114
FY20122
FY20132
FY201410
FY20154
FY20166
FY201710
FY20185
FY201911
FY20201
FY20222
FY20236
FY202411
FY202528
FY202610
Time series: 16 points from FY2010 to FY2026
Time series
PeriodValue
FY20102
FY20114
FY20122
FY20132
FY201410
FY20154
FY20166
FY201710
FY20185
FY201911
FY20201
FY20222
FY20236
FY202411
FY202528
FY202610

This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.

Compare KBI Biopharma, Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.